HWM
RDY icon

HB Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

HB Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
19,136
+3,624
+23% +$48.9K ﹤0.01% 1414
2026
Q1 		$215K Buy
+15,512
New +$216K ﹤0.01% 1399
2025
Q3 		– Sell
-12,050
Closed -$181K – 1366
2025
Q2 		$181K Buy
+12,050
New +$172K ﹤0.01% 1115

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HB Wealth Management's RDY Position: Q2 2026 in Review

HB Wealth Management increased its Dr. Reddy's Laboratories (RDY) stake by 23% in Q2 2026, buying an estimated $48.9K and bringing the position to 19,136 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

HB Wealth Management first reported a position in RDY in Q2 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • HB Wealth Management held 19,136 shares of Dr. Reddy's Laboratories worth $277K as of Q2 2026.
  • HB Wealth Management bought 3,624 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $48.9K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #1414 holding.
  • HB Wealth Management first reported a position in Dr. Reddy's Laboratories in Q2 2025 and has held it in 3 quarters since.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.